Michael Robert Martin Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity

Michael Robert Martin is Chief Business Officer of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 259,162 shares of AUPH, which is worth approximately $2.3 Million. The most recent transaction as insider was on Mar 02, 2023, when has been sold 107,202 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 259K

0% 3M change

0% 12M change

Total Value Held $2.3 Million

Michael Robert Martin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 02 2023	BUY Grant, award, or other acquisition	-	107,202 Added 29.26%	259,162 Common Stock
Nov 07 2022	BUY Open market or private purchase	$154,800 $5.16 p/Share	30,000 Added 25.1%	89,512 Common Stock
Mar 02 2022	SELL Open market or private sale	$58,236 $12.01 p/Share	4,849 Reduced 7.53%	59,512 Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	8,500 Added 11.67%	64,361 Common Stock
Nov 11 2021	SELL Open market or private sale	$835,780 $28.82 p/Share	29,000 Reduced 30.25%	66,861 Common Stock
Nov 11 2021	SELL Open market or private sale	$324,500 $29.5 p/Share	11,000 Reduced 16.45%	55,861 Common Shares
Nov 11 2021	BUY Exercise of conversion of derivative security	$533,020 $18.38 p/Share	29,000 Added 23.23%	95,861 Common Stock
Nov 10 2021	SELL Open market or private sale	$1,854,600 $30.91 p/Share	60,000 Reduced 47.3%	66,861 Common Shares
Nov 09 2021	SELL Open market or private sale	$1,508,500 $30.17 p/Share	50,000 Reduced 28.27%	126,861 Common Shares
Nov 01 2021	SELL Open market or private sale	$1,423,800 $31.64 p/Share	45,000 Reduced 20.28%	176,861 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$144,000 $3.2 p/Share	45,000 Added 16.86%	221,861 Common Stock
Sep 21 2021	SELL Open market or private sale	$2,101,750 $24.02 p/Share	87,500 Reduced 33.1%	176,861 Common Shares
Sep 21 2021	BUY Exercise of conversion of derivative security	$867,125 $9.91 p/Share	87,500 Added 24.87%	264,361 Common Stock
Sep 20 2021	SELL Open market or private sale	$617,310 $21.66 p/Share	28,500 Reduced 13.88%	176,861 Common Shares
Sep 20 2021	BUY Exercise of conversion of derivative security	$151,050 $5.3 p/Share	28,500 Added 12.19%	205,361 Common Stock
Sep 14 2021	SELL Open market or private sale	$957,440 $21.76 p/Share	44,000 Reduced 19.92%	176,861 Common Shares
Sep 14 2021	SELL Open market or private sale	$1,907,100 $21.19 p/Share	90,000 Reduced 33.73%	176,861 Common Stock
Sep 14 2021	BUY Exercise of conversion of derivative security	$233,200 $5.3 p/Share	44,000 Added 16.61%	220,861 Common Stock
Sep 14 2021	BUY Exercise of conversion of derivative security	$382,500 $4.25 p/Share	90,000 Added 25.22%	266,861 Common Stock
Sep 13 2021	BUY Exercise of conversion of derivative security	$132,500 $5.3 p/Share	25,000 Added 11.02%	201,861 Common Shares
Sep 10 2021	SELL Open market or private sale	$495,000 $19.8 p/Share	25,000 Reduced 12.38%	176,861 Common Shares
Sep 07 2021	SELL Open market or private sale	$135,750 $18.1 p/Share	7,500 Reduced 4.07%	176,861 Common Stock
Aug 26 2021	SELL Open market or private sale	$400,725 $17.81 p/Share	22,500 Reduced 10.88%	184,361 Common Stock
Aug 09 2021	SELL Open market or private sale	$80,050 $16.01 p/Share	5,000 Reduced 2.36%	206,861 Common Stock
Jul 28 2021	SELL Open market or private sale	$69,300 $13.86 p/Share	5,000 Reduced 2.31%	211,861 Common Stock

MRM

Michael Robert Martin

Chief Business Officer

Victoria, A1

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Value

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aurinia Pharmaceuticals Inc.

Track Activities on AUPH

Account